Overview
Jerald Radich is an Oncologist in Seattle, Washington. Dr. Radich has been practicing medicine for over 42 years and is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL). Dr. Radich is currently accepting new patients.
His clinical research consists of co-authoring 222 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 51 articles and participated in 1 clinical trial in the study of Acute Myeloid Leukemia (AML).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- PPO
- EPO
- PPO
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
The Association Of University Physicians
Frederick Appelbaum is an Oncologist in Seattle, Washington. Dr. Appelbaum is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, and Myelodysplastic Syndrome (MDS). Dr. Appelbaum is currently accepting new patients.
The Association Of University Physicians
Bart Scott is an Oncologist in Seattle, Washington. Dr. Scott is rated as an Elite provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Leukemia, and Bone Marrow Aspiration. Dr. Scott is currently accepting new patients.
The Association Of University Physicians
Mary-elizabeth Percival is a Hematologist and an Oncologist in Seattle, Washington. Dr. Percival is rated as a Distinguished provider by MediFind in the treatment of Acute Myeloid Leukemia (AML). Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Percival is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Acute Myeloid Leukemia (AML)
- Chronic Myelogenous Leukemia (CML)
- LeukemiaDr. Radich isElite. Learn about Leukemia.
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Radich isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Childhood Acute Myeloid LeukemiaDr. Radich isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Radich isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Myelomonocytic LeukemiaDr. Radich isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Radich isExperienced. Learn about Acute Promyelocytic Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Radich isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Radich isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelomonocytic Leukemia (CMML)Dr. Radich isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Familial Wilms Tumor 2Dr. Radich isExperienced. Learn about Familial Wilms Tumor 2.